Besunyen Holdings Company Limited (0926.HK)
- Previous Close
3.930 - Open
3.830 - Bid 3.830 x --
- Ask 4.040 x --
- Day's Range
3.830 - 3.840 - 52 Week Range
2.500 - 5.300 - Volume
11,000 - Avg. Volume
73,148 - Market Cap (intraday)
468.279M - Beta (5Y Monthly) 1.16
- PE Ratio (TTM)
-- - EPS (TTM)
-1.410 - Earnings Date Mar 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 28, 2021
- 1y Target Est
--
Besunyen Holdings Company Limited engages in the research and development, production, promotion, and sale of therapeutic tea products and pharmaceuticals in the People's Republic of China and internationally. The company operates through Tea Products, and Weight Loss and Other Medicines segments. It offers its therapeutic tea products under the Besunyen brand comprising Besunyen Detox Tea and Besunyen Slimming Tea. The company also provides functional teas, such as Besunyen Fit Tea and Besunyen Relief Tea, as well as sells over the counter (OTC) medicines comprising Besunyen Orlistat weight-loss medicines, nutrition meal replacements, probiotics, and enzymes. It sells its products through OTC pharmacies, pharmaceutical third-party terminals, and distributors and sub-distributors, as well as through e-commerce platforms. The company was founded in 2000 and is based in Central, Hong Kong. Besunyen Holdings Company Limited operates as a subsidiary of Foreshore Holding Group Limited.
ir.besunyen.com179
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 0926.HK
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0926.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0926.HK
Valuation Measures
Market Cap
468.28M
Enterprise Value
200.38M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.80
Price/Book (mrq)
0.78
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
-1.61
Financial Highlights
Profitability and Income Statement
Profit Margin
-55.12%
Return on Assets (ttm)
-8.69%
Return on Equity (ttm)
-19.81%
Revenue (ttm)
542.88M
Net Income Avi to Common (ttm)
-159.1M
Diluted EPS (ttm)
-1.410
Balance Sheet and Cash Flow
Total Cash (mrq)
252.79M
Total Debt/Equity (mrq)
0.92%
Levered Free Cash Flow (ttm)
-25.79M
Company Insights: 0926.HK
0926.HK does not have Company Insights